India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
Investment to expand manufacturing and global medicine supply capacity
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Subscribe To Our Newsletter & Stay Updated
